ALLOKIN-ALPHA HOME-MADE ANTIVIRUS NEW-GENERATION DRUG FOR HERPES AND PAPILLOMA VIRAL INFECTION (HPV) TREATMENT FAREWELL TO VIRUS! RUEnglishUA
INSTRUCTION FOR USE ¬идео о проблеме впч PATIENT FEEDBACK
SECTION FOR SPECIALISTS

The available treatment ways of Herpes Zoster

All the information contained on this informational resource is intended exclusively for practitioners and cannot be used by the site visitors for self-diagnosing and prescribing treatment without a previous consultation with the doctor.

The main goals of Herpes Zoster treatment: it is necessary to interrupt the replication of HZV (Herpes Zoster Virus) to prevent the development of neurological disorders, postdoctoral neuralgia (PDN), zoster-associated pain, prevention of the rash spread, the development of meningoencephalitis and ophthalmic herpes.

The use of antiviral drugs in clinical practice is associated with the formation of resistant viruses strains to chemotherapeutic agents. It significantly reduces the efficiency.

1.The drugs to suppress the replication of the virus are used for the treatment of HZ (Herpes Zoster) - Acyclovir and its analogues.

It is possible that some patients are insensible to the receiving of famciclovir and it can be explained by the purpose of the drug: 1) inadequate dosages and also 2) inappropriate route of administration. The attempt of accepting the antiherpetic drugs in high doses in long course can be used, for example, acyclovir 4000 mg/day for 10-14 days. Though, the results of treatment are not always encouraging enough (A. G. Rakhmanova, et al., 2001). In some patients PSV (prevention of significant violations), developing on the background of HZ is not relieved with the prescribing of specific antiviral drugs, but has a good respond to the antiherpetic immunoglobulins of directed action (IGDA).

2.The IGDA drugs (IV-th generation, for example, gabriglobin) possess the broad immunomodulatory activity and have the anti-inflammatory effect.
The use of hyperimmune globulin may be indicated prophylactically in the group of patients with increased risk of PZV (Hugler et al., 2002). It denies the participation of the virus in the genesis of PZV and confirms the action of immune-mediated mechanisms. The poor prognostic is a depression of cell-mediated immunological reactions, because the risk of HZV promotion increases significantly. An early appointment of the antiherpetic drugs reduces the risk of development of a syndrome of PZV by 30%.

The antiherpetic chemical drugs stopping quickly and effectively the strong symptoms of HV, do not prevent the repeated recurrence of Herpes and do not reduce the frequency of relapses. To increase the effectiveness of treatment it is necessary to include the immunobiological means into the schemes of treatment, which can assist the correction of the patient's immunological status, and also the pathogenetic drugs to facilitate the patient's condition (V. A. Isakov and others, 2004; 2006).

Read more:

Ask your gynecologist if he (she) has an experience in treatment of human papillomavirus infection to the complete removal of human papilloma virus from the body?

Homepage   |   Feedback   |   Site Map   |   Job Vacancies   |   Contacts
© 2004—2017 Brand-Pharm Ltd. All information contained on this website is intended only for medical specialists and cannot be used by visitors for self-diagnosis and treatment. Consult your physician, do not start self-medication!
The website creation and promotion: Alisa Design
яндекс.ћетрика